drugset / Trial / NCT00627302

Efficacy of PEG-400 and Systane Artificial Tears (Alcon) on Quality of Vision

NCT00627302

Phase 4 Completed 40 enrolled Bp Consulting, Inc
RandomizedParallel-groupDouble-blind

Summary

To evaluate the effect of PEG-400 and Systane on quality of vision after LASIK.

Timeline

Start
2008-02
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator PEG-400 Unknown Other
Comparator Systane Other / unclassified Other

Indications